These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial. Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637 [TBL] [Abstract][Full Text] [Related]
9. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception. Dhillon-Smith RK; Middleton LJ; Sunner KK; Cheed V; Baker K; Farrell-Carver S; Bender-Atik R; Agrawal R; Bhatia K; Edi-Osagie E; Ghobara T; Gupta P; Jurkovic D; Khalaf Y; MacLean M; McCabe C; Mulbagal K; Nunes N; Overton C; Quenby S; Rai R; Raine-Fenning N; Robinson L; Ross J; Sizer A; Small R; Tan A; Underwood M; Kilby MD; Boelaert K; Daniels J; Thangaratinam S; Chan SY; Coomarasamy A N Engl J Med; 2019 Apr; 380(14):1316-1325. PubMed ID: 30907987 [TBL] [Abstract][Full Text] [Related]
10. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial. Cheung KW; Seto MTY; Ng EHY Trials; 2020 Jan; 21(1):121. PubMed ID: 32000820 [TBL] [Abstract][Full Text] [Related]
11. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572 [TBL] [Abstract][Full Text] [Related]
12. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM). Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J Health Technol Assess; 2018 Jun; 22(35):1-304. PubMed ID: 29945711 [TBL] [Abstract][Full Text] [Related]
13. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885 [TBL] [Abstract][Full Text] [Related]
14. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571 [TBL] [Abstract][Full Text] [Related]
15. Effects of a Chinese Patent Medicine Gushen'antai Pills on Ongoing Pregnancy Rate of Hormone Therapy FET Cycles: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cao XL; Song JY; Zhang XX; Chen YH; Teng YL; Liu HP; Deng TY; Sun ZG Front Endocrinol (Lausanne); 2020; 11():581719. PubMed ID: 33071986 [TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study. Brizot ML; Hernandez W; Liao AW; Bittar RE; Francisco RPV; Krebs VLJ; Zugaib M Am J Obstet Gynecol; 2015 Jul; 213(1):82.e1-82.e9. PubMed ID: 25731690 [TBL] [Abstract][Full Text] [Related]
17. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Rode L; Klein K; Nicolaides KH; Krampl-Bettelheim E; Tabor A; Ultrasound Obstet Gynecol; 2011 Sep; 38(3):272-80. PubMed ID: 21739497 [TBL] [Abstract][Full Text] [Related]
18. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial. Ismail AM; Abbas AM; Ali MK; Amin AF J Matern Fetal Neonatal Med; 2018 Feb; 31(3):388-394. PubMed ID: 28114846 [TBL] [Abstract][Full Text] [Related]
19. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth. Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230 [TBL] [Abstract][Full Text] [Related]
20. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O; BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]